M H Vendelbo1, A B Møller2, J T Treebak3, L C Gormsen4, L J Goodyear5, J F P Wojtaszewski6, J O L Jørgensen7, N Møller7, N Jessen8. 1. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Nuclear Medicine and PET center, Aarhus University Hospital, Aarhus, Denmark; 2. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark; Research Laboratory for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark; 3. Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Integrative Physiology, University of Copenhagen, Copenhagen, Denmark; 4. Department of Nuclear Medicine and PET center, Aarhus University Hospital, Aarhus, Denmark; 5. Joslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6. Molecular Physiology Group, Department of Nutrition, Exercise and Sports, The August Krogh Centre, University of Copenhagen, Copenhagen, Denmark; and. 7. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark; 8. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark; Research Laboratory for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark Niels.Jessen@ki.au.dk.
Abstract
BACKGROUND: phosphorylation of AS160 and TBC1D1 plays an important role for GLUT4 mobilization to the cell surface. The phosphorylation of AS160 and TBC1D1 in humans in response to acute exercise is not fully characterized. OBJECTIVE: to study AS160 and TBC1D1 phosphorylation in human skeletal muscle after aerobic exercise followed by a hyperinsulinemic euglycemic clamp. DESIGN: eight healthy men were studied on two occasions: 1) in the resting state and 2) in the hours after a 1-h bout of ergometer cycling. A hyperinsulinemic euglycemic clamp was initiated 240 min after exercise and in a time-matched nonexercised control condition. We obtained muscle biopsies 30 min after exercise and in a time-matched nonexercised control condition (t = 30) and after 30 min of insulin stimulation (t = 270) and investigated site-specific phosphorylation of AS160 and TBC1D1. RESULTS: phosphorylation on AS160 and TBC1D1 was increased 30 min after the exercise bout, whereas phosphorylation of the putative upstream kinases, Akt and AMPK, was unchanged compared with resting control condition. Exercise augmented insulin-stimulated phosphorylation on AS160 at Ser(341) and Ser(704) 270 min after exercise. No additional exercise effects were observed on insulin-stimulated phosphorylation of Thr(642) and Ser(588) on AS160 or Ser(237) and Thr(596) on TBC1D1. CONCLUSIONS: AS160 and TBC1D1 phosphorylations were evident 30 min after exercise without simultaneously increased Akt and AMPK phosphorylation. Unlike TBC1D1, insulin-stimulated site-specific AS160 phosphorylation is modified by prior exercise, but these sites do not include Thr(642) and Ser(588). Together, these data provide new insights into phosphorylation of key regulators of glucose transport in human skeletal muscle.
BACKGROUND: phosphorylation of AS160 and TBC1D1 plays an important role for GLUT4 mobilization to the cell surface. The phosphorylation of AS160 and TBC1D1 in humans in response to acute exercise is not fully characterized. OBJECTIVE: to study AS160 and TBC1D1 phosphorylation in human skeletal muscle after aerobic exercise followed by a hyperinsulinemic euglycemic clamp. DESIGN: eight healthy men were studied on two occasions: 1) in the resting state and 2) in the hours after a 1-h bout of ergometer cycling. A hyperinsulinemic euglycemic clamp was initiated 240 min after exercise and in a time-matched nonexercised control condition. We obtained muscle biopsies 30 min after exercise and in a time-matched nonexercised control condition (t = 30) and after 30 min of insulin stimulation (t = 270) and investigated site-specific phosphorylation of AS160 and TBC1D1. RESULTS: phosphorylation on AS160 and TBC1D1 was increased 30 min after the exercise bout, whereas phosphorylation of the putative upstream kinases, Akt and AMPK, was unchanged compared with resting control condition. Exercise augmented insulin-stimulated phosphorylation on AS160 at Ser(341) and Ser(704) 270 min after exercise. No additional exercise effects were observed on insulin-stimulated phosphorylation of Thr(642) and Ser(588) on AS160 or Ser(237) and Thr(596) on TBC1D1. CONCLUSIONS:AS160 and TBC1D1 phosphorylations were evident 30 min after exercise without simultaneously increased Akt and AMPK phosphorylation. Unlike TBC1D1, insulin-stimulated site-specific AS160 phosphorylation is modified by prior exercise, but these sites do not include Thr(642) and Ser(588). Together, these data provide new insights into phosphorylation of key regulators of glucose transport in human skeletal muscle.
Authors: Carol A Witczak; Niels Jessen; Daniel M Warro; Taro Toyoda; Nobuharu Fujii; Mark E Anderson; Michael F Hirshman; Laurie J Goodyear Journal: Am J Physiol Endocrinol Metab Date: 2010-03-09 Impact factor: 4.310
Authors: L C Gormsen; N Jessen; J Gjedsted; S Gjedde; H Nørrelund; S Lund; J S Christiansen; S Nielsen; O Schmitz; N Møller Journal: J Clin Endocrinol Metab Date: 2007-03-06 Impact factor: 5.958
Authors: Kathryn M Geraghty; Shuai Chen; Jean E Harthill; Adel F Ibrahim; Rachel Toth; Nick A Morrice; Franck Vandermoere; Greg B Moorhead; D Grahame Hardie; Carol MacKintosh Journal: Biochem J Date: 2007-10-15 Impact factor: 3.857
Authors: Dorte E Kristensen; Peter H Albers; Clara Prats; Otto Baba; Jesper B Birk; Jørgen F P Wojtaszewski Journal: J Physiol Date: 2015-02-27 Impact factor: 5.182
Authors: Haiyan Wang; Edward B Arias; Mark W Pataky; Laurie J Goodyear; Gregory D Cartee Journal: Am J Physiol Endocrinol Metab Date: 2018-08-21 Impact factor: 4.310
Authors: Mark W Pataky; Sydney L Van Acker; Rhea Dhingra; Marina M Freeburg; Edward B Arias; Kentaro Oki; Haiyan Wang; Jonas T Treebak; Gregory D Cartee Journal: Am J Physiol Endocrinol Metab Date: 2019-10-01 Impact factor: 4.310
Authors: Robert M Edinburgh; Aaron Hengist; Harry A Smith; Rebecca L Travers; Francoise Koumanov; James A Betts; Dylan Thompson; Jean-Philippe Walhin; Gareth A Wallis; D Lee Hamilton; Emma J Stevenson; Kevin D Tipton; Javier T Gonzalez Journal: Am J Physiol Endocrinol Metab Date: 2018-08-14 Impact factor: 4.310